ChemoCentryx ContactKeep Me PostedSite Map
Medicines in MotionChemoCentryx is a clinical stage focused pharmaceutical company creating small molecule medicines for autoimmune diseases, inflammatory disorders and oncology.
Announcement
ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
ChemoCentryx Achieves $5 Million Milestone from GlaxoSmithKline for Nomination of CCR1 Small Molecule Development Candidate
  More News >
GET MORE information about ChemoCentryx's products. LEARN ABOUT chemokines and diseases. FIND OUT about clinical trials of Traficet-EN?for IBD.
GET MORE information about ChemoCentryx's products. LEARN ABOUT chemokines and diseases. FIND OUT about clinical trials of Traficet-EN for IBD.

© 2008 ChemoCentryx, Inc. Legal | Site User's Guide